| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 51,025 | 46,635 | 32,938 | | Selling General and Administrative | 9,702 | 9,058 | 9,287 | | Non Recurring | 2,810 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (63,537) | (55,693) | (42,225) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 779 | 2,699 | 2,826 | | Earnings Before Interest And Taxes | (62,758) | (52,994) | (39,399) | | Interest Expense | 96 | 82 | 46 | | Income Before Tax | (62,854) | (53,076) | (39,445) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (62,854) | (53,076) | (39,445) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (62,854) | (53,076) | (39,445) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($62,854) | ($53,076) | ($39,445) |
|
0.95% Nasdaq 
0.09 (69.23%) 
Income Statement
